Trials / Sponsors / Kinaset Therapeutics Inc
Kinaset Therapeutics Inc
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Phase 2 Dose Ranging Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients Severe Asthma | Phase 2 | 2026-06-01 |
| Completed | Single and Multiple Ascending Dose Study of KN-002 Asthma COPD | Phase 1 | 2021-07-30 |